Aloisine B

CAS No. 496864-14-3

Aloisine B( —— )

Catalog No. M36276 CAS No. 496864-14-3

Aloisine B (AloisineB) inhibited cyclin-dependent kinase and glycogen synthase kinase with IC50 values of 0.85 μM and 0.75 μM, respectively.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 472 In Stock
10MG 644 In Stock
25MG 905 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Aloisine B
  • Note
    Research use only, not for human use.
  • Brief Description
    Aloisine B (AloisineB) inhibited cyclin-dependent kinase and glycogen synthase kinase with IC50 values of 0.85 μM and 0.75 μM, respectively.
  • Description
    Aloisine B (AloisineB) inhibited cyclin-dependent kinase and glycogen synthase kinase with IC50 values of 0.85 μM and 0.75 μM, respectively. Aloisine B has antiviral activity and can be used to study Alzheimer's, diabetes, HIV and Parkinson's.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    PI3K/Akt/mTOR signaling
  • Target
    GSK-3
  • Recptor
    GSK-3 | CDK
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    496864-14-3
  • Formula Weight
    271.74
  • Molecular Formula
    C15H14ClN3
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    C(C)(C)C1=C(NC=2C1=NC=CN2)C3=CC=C(Cl)C=C3
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • LY2090314

    LY2090314 is a potent GSK-3 inhibitor for GSK-3α/β with IC50 of 1.5 nM/0.9 nM.

  • Tideglusib

    Tideglusib is an irreversible, non ATP-competitive GSK-3β inhibitor with IC50 of 60 nM in a cell-free assay.

  • GSK-3β inhibitor 1 (...

    GSK-3β inhibitor 1 is a glycogen synthase kinase 3β (GSK-3β) inhibitor and demonstrates high antidiabetic efficacy.